Related Experiment Video

Updated: Sep 2, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction

M Ohtsuki1, J Massagué

  • 1Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Molecular and Cellular Biology
|January 1, 1992
PubMed

Insights

Transforming growth factor-beta 1 (TGF-beta 1) triggers junB and PAI-1 expression and prevents RB phosphorylation. The inhibitor H7 blocks these TGF-beta 1 responses, suggesting a protein kinase involvement.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta 1 (TGF-beta 1) is a key regulator of cellular processes.
  • TGF-beta 1 influences gene expression, cell cycle progression, and extracellular matrix production.
  • Understanding the molecular mechanisms of TGF-beta 1 signaling is crucial for various biological contexts.

Purpose of the Study:

  • To investigate the early molecular events mediated by TGF-beta 1 in Mv1Lu lung epithelial cells.
  • To identify the specific protein kinases involved in TGF-beta 1-induced cellular responses.
  • To elucidate the mechanism by which H7 inhibits TGF-beta 1 signaling.

Main Methods:

  • Treatment of Mv1Lu cells with TGF-beta 1 and various kinase inhibitors (H7, H8, H9, staurosporine).
  • Analysis of junB transcription factor and plasminogen activator inhibitor-1 (PAI-1) mRNA expression.
  • Assessment of RB retinoblastoma susceptibility gene product phosphorylation.
  • Evaluation of PAI-1 deposition into the extracellular matrix.

Main Results:

  • TGF-beta 1 rapidly increased junB and PAI-1 expression and prevented RB phosphorylation.
  • The serine/threonine protein kinase inhibitor H7 blocked these TGF-beta 1-induced responses.
  • H7 did not affect basal gene expression or RB phosphorylation when added alone.
  • H8 and H9 were less potent inhibitors than H7, while staurosporine and PMA had no effect on the PAI-1 response.

Conclusions:

  • A protein serine/threonine kinase(s) is likely involved in mediating early TGF-beta 1 responses.
  • H7 effectively inhibits key TGF-beta 1-induced signaling pathways in lung epithelial cells.
  • These findings provide insights into the signaling cascade initiated by TGF-beta 1.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...